Colombia has the third largest pharmaceutical market in Latin America, due to its growing manufacturing industry and the arrival of multiple global players to the country.
Bogota, pharmaceutical capital
It is one of the main pharmaceutical cities in Latin America. It concentrates 66% of drug manufacturers, 65% of drug wholesalers, 49% of jobs in the sector, 47% of exports and 87% of Colombia’s pharmaceutical imports.
It also has a favorable climate for the handling and manufacturing of pharmaceuticals, with an average annual temperature of 14°C and no seasons, which generates savings in production and energy costs.
At the same time, Bogota is home to the country’s most important decision makers and the headquarters of Colombia’s drug surveillance and control entity (INVIMA), which is an international reference entity, qualified with the highest rank of the Pan American Health Organization.
Sources: Ministry of Health, Ministry of Industry, Trade and Tourism, World Bank, Bogota Healthcare Cluster.
If you need more detailed information, find in the lower part the information of our investment officers in charge of this sector.
Updated (mm/dd/yyyy): 26/12/2022
Contact an advisor
Contact Invest in Bogotá to receive all the information and advice you need to invest in Bogota and Colombia.
Need more information?
Contact Invest in Bogota to receive all the information and advice you need to invest in Bogota and Colombia.